Mr. Shantha Bandara
Sunshine Healthcare Lanka (SHL), the healthcare arm of the diversified Sri Lankan conglomerate Sunshine Holdings has appointed Shantha Bandara as the Chief Executive Officer of its pharmaceutical division. The appointment came into effect from July 01, 2020.
Mr. Bandara, who was the Chief Operating Officer of Sunshine Pharmaceuticals, counts more than 23 years of experience in the pharmaceutical industry. He joined Sunshine Healthcare in 2011 and rose through the ranks to become the COO in 2018, where he has been spearheading the pharmaceutical business to reach newer heights and become one of the leading healthcare companies in Sri Lanka since then. He has been instrumental in growing the healthcare business to be the key driver of the group’s financial performance, helping Sunshine Holdings to sustain its growth over the last two years amidst tough macroeconomic conditions, the company said in a media release.
Customs have detected 228 mobile phones and tabs valued at over Rs 30 million left behind in the duty free shopping complex at the Banaranaike International Airport today, Customs officials said.
Read this week’s Sunday Times for your interesting articles including the ’’5th Column’’.
Leave Comments